Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,601 to 1,620 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reverse genetic engineering of simian rotaviruses with temperature-sensitive lesions in VP1, VP2, and VP6. | Virus Res | 2021 | 34146610 | PubTator, text mining | PubMed |
| The C/EBPβ-Dependent Induction of TFDP2 Facilitates Porcine Reproductive and Respiratory Syndrome Virus Proliferation. | Virol Sin | 2021 | 34138404 | PubTator, text mining | PubMed |
| Metagenomic analysis of fecal and tissue samples from 18 endemic bat species in Switzerland revealed a diverse virus composition including potentially zoonotic viruses. | PLoS One | 2021 | 34133435 | PubTator, text mining | PubMed |
| The impact of high-resolution structural data on stemming the COVID-19 pandemic. | Curr Opin Virol | 2021 | 34130040 | PubTator, text mining | PubMed |
| Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity. | Front Immunol | 2021 | 34127926 | PubTator, text mining | PubMed |
| Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19. | Mol Cell Biol | 2021 | 34124934 | PubTator, text mining | PubMed |
| Anti-SARS-CoV-2 Natural Products as Potentially Therapeutic Agents. | Front Pharmacol | 2021 | 34122058 | PubTator, text mining | PubMed |
Screening of FDA-approved compound library identifies potential small-molecule inhibitors of SARS-CoV-2 non-structural proteins NSP1, NSP4, NSP6 and NSP13: molecular modeling and molecular dynamics studies. | J Proteins Proteom | 2021 | 34121824 | PubTator, text mining | PubMed |
| Revealing the Structural Plasticity of SARS-CoV-2 nsp7 and nsp8 Using Structural Proteomics. | J Am Soc Mass Spectrom | 2021 | 34121407 | PubTator, text mining | PubMed |
| New perspective towards therapeutic regimen against SARS-CoV-2 infection. | J Infect Public Health | 2021 | 34118735 | PubTator, text mining | PubMed |
| Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy. | Signal Transduct Target Ther | 2021 | 34117216 | PubTator, text mining | PubMed |
| Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit. | J Infect Dis | 2021 | 34111271 | PubTator, text mining | PubMed |
| Profiling COVID-19 Genetic Research: A Data-Driven Study Utilizing Intelligent Bibliometrics. | Front Res Metr Anal | 2021 | 34109284 | PubTator, text mining | PubMed |
| Understanding the SARS-CoV-2 virus to mitigate current and future pandemic(s). | Virusdisease | 2021 | 34109260 | PubTator, text mining | PubMed |
| Full genome-based characterization of G4P[6] rotavirus strains from diarrheic patients in Thailand: Evidence for independent porcine-to-human interspecies transmission events. | Virus Genes | 2021 | 34106412 | PubTator, text mining | PubMed |
| Assessing the impact of alcohol consumption on the genetic contribution to mean corpuscular volume. | Hum Mol Genet | 2021 | 34104963 | PubTator, text mining | PubMed |
| Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review. | Eur J Med Res | 2021 | 34103090 | PubTator, text mining | PubMed |
| Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro. | Antimicrob Agents Chemother | 2021 | 34097489 | PubTator, text mining | PubMed |
| Finding Druggable Sites in Proteins Using TACTICS. | J Chem Inf Model | 2021 | 34096704 | PubTator, text mining | PubMed |
| Virtual Screening of Phytochemicals by Targeting HR1 Domain of SARS-CoV-2 S Protein: Molecular Docking, Molecular Dynamics Simulations, and DFT Studies. | Biomed Res Int | 2021 | 34095308 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=81